STOCK TITAN

Bone Biologics Corp Warrants (BBLGW) Net Income by Year

BBLGW

Bone Biologics Corp Warrants reported a net loss of $3.1M in fiscal year 2025. This represents an increase of 24.4% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Bone Biologics Corp Warrants has filed alongside them.

FY2025 annual
Net Income -$3.1M
YoY +24.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BBLGW Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$3.1M+24.4%-$4.1M+54.0%-$8.9M-502.8%-$1.5M+7.8%-$1.6M+11.7%-$1.8MN/A-$4.4MN/AN/AN/A-$4.4MN/AN/A-$938K

BBLGW Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$774K-4.5%-$766K+24.7%N/A-$667K+29.1%-$741K+5.5%-$1.0M-17.5%N/A-$941K+51.0%-$784K+55.7%-$866K+76.7%N/A-$1.9M-57.4%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Bone Biologics Corp Warrants financials

Frequently Asked Questions

What was Bone Biologics Corp Warrants's net income in fiscal year 2025?

Bone Biologics Corp Warrants reported a net loss of $3.1M in fiscal year 2025.

How fast is Bone Biologics Corp Warrants's net income growing?

Bone Biologics Corp Warrants (BBLGW) net income rose by 24.4% year over year, from -$4.1M to -$3.1M in fiscal year 2025.

How has Bone Biologics Corp Warrants's net income changed over the years?

Across the 15 fiscal years this page covers, Bone Biologics Corp Warrants (BBLGW) net income went from -$938K in fiscal year 2011 to -$3.1M in fiscal year 2025.

Bone Biologics Corp Warrants (BBLGW) reported -$774K in net income in Q2 2026. This represents a decrease of 4.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Bone Biologics Corp Warrants (BBLGW) reported on that line in every period on record.